Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor - PubMed (original) (raw)

Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor

A Migliaccio et al. EMBO J. 1998.

Abstract

The molecular mechanisms by which ovarian hormones stimulate growth of breast tumors are unclear. It has been reported previously that estrogens activate the signal-transducing Src/p21(ras)/Erk pathway in human breast cancer cells via an interaction of estrogen receptor (ER) with c-Src. We now show that progestins stimulate human breast cancer T47D cell proliferation and induce a similar rapid and transient activation of the pathway which, surprisingly, is blocked not only by anti-progestins but also by anti-estrogens. In Cos-7 cells transfected with the B isoform of progesterone receptor (PRB), progestin activation of the MAP kinase pathway depends on co-transfection of ER. A transcriptionally inactive PRB mutant also activates the signaling pathway, demonstrating that this activity is independent of transcriptional effects. PRB does not interact with c-Src but associates via the N-terminal 168 amino acids with ER. This association is required for the signaling pathway activation by progestins. We propose that ER transmits to the Src/p21(ras)/Erk pathway signals received from the agonist-activated PRB. These findings reveal a hitherto unrecognized cross-talk between ovarian hormones which could be crucial for their growth-promoting effects on cancer cells.

PubMed Disclaimer

Similar articles

Cited by

References

    1. J Biol Chem. 1990 Jan 25;265(3):1376-80 - PubMed
    1. EMBO J. 1990 May;9(5):1603-14 - PubMed
    1. Endocr Rev. 1990 May;11(2):266-301 - PubMed
    1. Methods Enzymol. 1991;201:362-70 - PubMed
    1. Science. 1991 Dec 13;254(5038):1636-9 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources